VLS Retatrutide Pen

VLS Retatrutide Pen
VLS Pharmaceuticals

VLS Retatrutide Pen

Retatrutide · Prefilled Injection Pen · 20mg / 40mg
In Stock 现货 -14% ✓ 批次可追溯 ✓ 第三方 COA 检测
£150.00 – £220.00
In stock - ships from UK warehouse
🚚 UK domestic delivery - cold chain / light-protected packaging
前往购买 / 询价

In short 产品简述

Retatrutide is a next-generation triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. This VLS pre-filled pen offers precise, convenient administration for metabolic and weight management research.

Specifications 规格参数

含量规格 Content 20mg / 40mg
剂型 Format 预充注射笔
浓度 Concentration 6.52mg/ml
活性成分 Ingredient Retatrutide
CAS 号 2381089-83-2

About the Product 产品详情

Janoshik Lab Verified

Independent third-party testing

Purity

6.52mg/ml

Content

🔗 Verify at

janoshik.com/verify

using key:

2HPDNTUWCH9K

| Tested: Sept 2025

VLS Retatrutide Pen

is a next-generation

triple agonist peptide

targeting GLP-1, GIP, and glucagon receptors simultaneously. This pre-filled

Retatrutide injection pen

offers convenient, precise administration for research into weight management, metabolic health, and appetite regulation. Available for

UK delivery

with fast dispatch.

Retatrutide Pen Specifications

Peptide

Retatrutide

Type

Triple Agonist

Format

Pre-filled Pen

Concentration

6.66mg/ml

Purity

Brand

VLS

VLS Retatrutide 20mg

Pre-filled Injection Pen

Retatrutide Research Benefits

Triple receptor action

Appetite regulation

Metabolic health

Weight management

Convenient format

How Retatrutide Works

Retatrutide

is a novel

triple agonist peptide

that activates three key receptors involved in metabolic regulation: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the glucagon receptor. This multi-receptor approach differentiates it from single or dual agonists like semaglutide or tirzepatide.

By targeting all three pathways, Retatrutide research has shown potential for enhanced effects on appetite suppression, glucose metabolism, and energy expenditure. Clinical trials have demonstrated significant interest in its application for obesity and type 2 diabetes research.

Retatrutide vs Tirzepatide vs Semaglutide

While

Semaglutide

targets only GLP-1 and

Tirzepatide

targets GLP-1 and GIP,

Retatrutide

adds glucagon receptor activation for a triple-action approach. Early research suggests this may offer advantages in metabolic studies, making Retatrutide pens increasingly sought after for laboratory investigation.

⚠️ FOR LABORATORY RESEARCH USE ONLY

NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE

Safety Classification:

Legal Notice:

This product is exclusively intended for in vitro laboratory research conducted in controlled environments by qualified research staff. It is not for pharmaceutical, domestic, or any other applications. The purchaser accepts that acquiring and using this material is governed by all relevant UK regulations concerning research chemicals.

Third-Party Testing 第三方检测

检测机构 LaboratoryJanoshik
查看 / 核验检测报告

What's in the Box 包装清单

  • 1 x prefilled injection pen with sealed needle tips (quantity per supplier packaging).

Usage 使用说明

  • Use a new sealed needle tip for each injection. Dial the scale and check the dose window. Administer per the dose set in the research protocol.

Handling & Storage 储存条件

  • Refrigerate at 2-8 C, do not freeze. Store in the original carton, protected from light. Use within the supplier-stated period after first opening.

Applications 应用方向

Retatrutide 减重代谢 血糖控制

For research purposes only 免责声明

Information on this entry is compiled from the public sales page (The Ped Shop) and is for research and reference only. Listed products are shown for research use, not sold as drugs or dietary supplements, and are not intended to diagnose, treat, cure or prevent any disease. Actual specification, price and stock are subject to the supplier page.

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.